Company: SRPT
Filing Date: 2025-11-03
Form Type: 8-K
Source: 0001193125-25-262591
Chunk: 1

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-11-03
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                                              
   Number                                                                                                                                               
     99.1      Press Release dated November 3, 2025                                                                                                     
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      The cover page from this Current Report on Form 8-K of Sarepta Therapeutics, Inc., formatted in Inline XBRL and included as Exhibit 101  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                            Sarepta Therapeutics, Inc.  
  Date:      November 3, 2025      By:      /s/ Douglas S. Ingram       
                                            Douglas S. Ingram